IL-33 induces IL-13-dependent cutaneous fibrosis

Area of Science:

• Immunology
• Dermatology
• Fibrosis Research

Background:

• Interleukin-33 (IL-33) is present in epithelial tissues, and its elevated levels correlate with fibrotic conditions like scleroderma.
• The direct impact of IL-33 release in skin tissue remains largely uninvestigated.

Purpose of the Study:

• To investigate the effects of dysregulated Interleukin-33 (IL-33) signaling in cutaneous tissues.
• To elucidate the cellular and molecular mechanisms underlying IL-33-induced skin fibrosis.

Main Methods:

• Subcutaneous administration of IL-33 in a murine model.
• Monitoring of cellular infiltration, gene expression (IL-13 mRNA), and extracellular matrix remodeling at the injection site.
• Utilizing IL-13 knockout and Delta dblGATA mice to assess the roles of IL-13 and eosinophils.

Main Results:

• IL-33 administration induced significant eosinophil and mononuclear cell accumulation, alongside increased IL-13 mRNA expression.
• Cutaneous fibrosis developed, characterized by altered expression of extracellular matrix genes like collagen VI and III.
• IL-33-induced fibrosis was dependent on both IL-13 and eosinophils, with eosinophils shown to secrete IL-13 upon IL-33 stimulation.

Conclusions:

• Interleukin-33 (IL-33) acts as a previously unrecognized profibrotic mediator in skin.
• Eosinophil-derived IL-13 plays a critical role in promoting IL-33-induced cutaneous fibrosis.
• Identified key cellular and molecular pathways involved in IL-33-mediated skin remodeling and fibrosis.